Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Salvus is a life science technology company that has developed a highly sensitive, portable interferometric detection platform. The technology, originally developed at the Georgia Institute of Technology, allows for the rapid identification of pathogens, chemicals, and biological markers in various liquid and gaseous matrices. The Salvus platform utilizes a proprietary optical waveguide sensor and a functionalized disposable chip to provide lab-quality results at the point of need. The company targets applications in healthcare diagnostics, food safety, and environmental monitoring, operating as a subsidiary of CJB Industries. By combining advanced optics with flexible surface chemistry, Salvus enables real-time monitoring and decision-making in the field.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Salvus.